GSTM1 and prostate carcinoma: This high Hb ratio agrees with observed low prostate cancer detection rates for random biopsy cores, which prompted changes in prostate cancer biopsy schemes from the classical sextant (6-core)25 to the current 12- to 24-core26,27 approach.